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We recently show ed a deficiency of cyclic AMP (cAMP)-
dependent protein kinases in psoriatic cells. In this work 
the effec ts of retinoids on cAMP-dependent protein kinases 
of fibrobl as ts from 7 normal subjects and 7 psoriatic pa-
tients were studied . The levels o f RI and RII (two forms 
of the cAMP-dependent pro tein kinases) present in control 
and retinoic acid-trea ted cells were quantitated by pho-
toaffmity labeling w ith [8-azido-32P] cAMP. In psoriatic fi-
broblas ts the levels o f RII are decreased or undetectable 
compared with those of no rmal fibroblas ts both in the 
cytosolic and membrane fractions. The amount of RI w as 
normal in the cytosol of fibro blas ts o f 5 ou t of 7 patients 
and decreased in 2 patients. M embrane-associated levels of 
RI w ere decreased in 5 patients and normal in 2 patients. 
Psoriasis les ions offer a model to stud y benign cell hy-perproliferation with abnormal diffe rentiation [1 ,2). The role of cyclic AMP (cAMP) in cellular growth is w idely debated [3, 4] . The regulato ry effects of cAMP in mam-malian cells are mediated th ro ugh the acti va tion o f the 
cAMP-dependent protein kinases [5 ,6]. T wo fo rms of the cAMP-
dependent protein kin ases have been identified and are referred 
to as types I and II. These two fo rms of the cAMP-dependent 
protein kinases differ in the nature o f their regul atory subunits 
(RI and RII) since their catalyti c subunits appear to be identical 
[7J . Recent evidence in several cell systems is consistent with the 
view that the type I isoenzy me of cAMP-dependent protein kinase 
has a positi ve role in cell proliferation, whereas the type II iso-
enzyme is involved in the modulation of cell di fferentia tion and 
growth inhibition [8-10J. 
While variable results have been reported for the intracellular 
cAMP levels present in psoriatic tissues [11,12], experimental 
evidence does suggest a role of cAMP in the manifestation of this 
hyperproli fe rati ve skin disease [11 ,13). Furtherm ore, we recently 
have shown decreased levels o f cAMP-dependent pro tein kinase 
activity in fibroblas ts and red blood cells obtained fro m psoriatic 
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SDS: sodium dodecyl sul fa te 
Retinoic acid trea tment indu ces an increase in the am ount 
of Rl and RII regulatory subunits when they are defi cient 
in the cytosolic and m embrane fractions of psoriatic fibro-
blas ts. Retinoic acid had no effect on RI and RII in normal 
fibroblas ts . In addition, with in vitro retinoic acid trea t-
ment the cAMP-dependent protein kinase activity, m ea-
sured in the fibroblasts of 4 psoriatic patients , was increased 
in the cy tosol in 2 patients and in the m embranes in all 4 
patients. In these studies , comparable results were obtained 
with fib ro blas ts cultu red fro m involved and uninvolved 
skin . T his in vitro effect of retinoids on cAMP-dependent 
protein kinases in psoriatic fibroblas ts may help to explain 
some of the in vivo therapeutic effects of retinoids . ] Invest 
D ermatol 89:105- 110, 1987 
subj ects. This decrease in protein kinase levels correlates well w ith 
the severity of the disease [1 4]. 
Retinoic acid derivati ves have been used with success as therapy 
in psorias is [15-1 7]. These compounds have been shown to in-
crease cAMP-dependent protein kin ase acti vity during differen-
tiation of tumoral cells [1 8]. These findings led us to study the 
effects of retinoic acid and o ther retinoid deri va tives on the ac-
tivity and distribution of the cAMP-dependent protein kinases in 
psoriatic fi bro blas ts. 
MA TERIALS AND METH O D S 
Reagents Trypsin (2 x crys tallized), collagenase (type II-5) , 8-
bro mo cAMP, cAMP, and kemptide were purchased fro m Sigma 
(S t. Louis, Missouri). Ham 's F1 2 medium and glutamine w ere 
fro m Flow Laboratories (Puteaux, France) , and fetal calf serum 
from Seromed (Berlin, F. R. G.). All-trans-vitamin A (retinoic acid), 
13-cis-retinoic acid , aro tinoid, and RO 101670 were generous gi fts 
fro m Hoffmann-LaRoche (Basel, Sw itzerland). [y-32PJATP was 
obtained from Amersham (Les Ulis, France), and [8-azido-32P] 
cAMP from ICN Pharmaceuticals (Cleveland , O hio) . Low-
molecular-weight standards were from Biorad (Richmond, Cali-
fornia). 
Fibroblasts in Culture Human fi broblas ts were isolated fro m 
normal and untrea ted psoriatic adult patients by enzy matic diges-
tion of small pieces (4 mm) of dermis from skin biopsies taken 
from nonlesional and lesional tissue. T he skin fragmen t was rin sed 
2 times with 5 1111 of wa rm (37°C) Ham 's F1 2 culture medium 
containing penicillin (50 U /ml) and streptomycin (50 jLg/ml). The 
washed skin sample then was min ced into small pieces and in-
cubated with try psin (2. 5 mg/ml) in 10 ml of H am 's F12 medium 
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for 1 h. The trypsini zed skin fragm ents were isolated by low-
speed centri fugation (1000 rpm for 3 min) and th en incubated in 
Ham 's F12 medium containing co llagenase (1 mg/ ml) for 12 h at 
37°C w ith shakin g in a ro tato ry in cubato r (N ew Brun swick). 
Cells were isolated from this incubation mi xture by centrifu gation 
at 400 g for 10 min , th e cell pellet res uspended in 5 ml of Ham 's 
F12 medium containing 20% feta l ca lf serum , penicillin (50 U / m l), 
and streptomycin (50 p,g/ ml) , and plated onto a 100-mm cell 
cul ture dish. Cells were grown in a 5% CO2 humidified atm os-
phere at 37°C and th e culture medium was chan ged every 3 days. 
For protein kinase determinations the cells we re used after their 
4th-5th passage. Where indi ca ted retinoic acid, o r derivatives, 
disso lved in absolu te eth ano l were added 1 day after plat ing to 
give a fina l concentration of 1 p,M. T he fin al concentration of 
ethanol in the medium did not alter cell g rowth morphology, o r 
protein ki nases levels. 
Preparation of Cellular Fractions All procedures were per-
formed at 0°_4°C. Cell s were washed 3 tim es wi th icc-cold bu ffe r 
[50 mM Tris-H C I, pH 7.S, 0.33 M sucrose, 1 mM M gCI2, leu-
pep tin (1 mg/50 ml)], harvested fro m the dish by scra ping and 
homogeni zed using a Oounce homogenizer. For photoaffi nity 
label ing, the homogenate was centrifu ged at SOO g for 10 min and 
the pel let was discarded. A crude plasma membrane fraction was 
obtained by centrifugin g the supernatant at 10,000 /o!. for 10 mi n. 
T he 10,000 g supernata nt was centrifuged at 100,000 g for 45 mi n 
and the resultin g superintant was used as the cy tosolic fract ion . 
Fo r protein kinase determinations th e homogenate was centri-
fuged for 5 min at 10,000 g in a minifu ge (Beckman) and the 
supernatant and pellet were assayed. 
Photoaffinity Labeling With [8-azido-32P ]cAMP Photoaf-
finit y labeling of the RI and lUI regul atory su buni ts of the cAMP-
dependent protein kin ase was perfo rm ed as described by Walter 
et al 11 9]. The rea ction mi xture (SO p,1) contained 50 mM 2[N-
Morpholino]ethane sulfonic acid, pH 6.2, 10 mM MgCI2, 1 p,M 
[S-azido-32P]cA MP and 100 p,g of cytosoli c o r membrane protein . 
Where indica ted 10 p,M cAMP was included to determine non-
specifi c labeling. Incubat ion was ca rried out for 60 min in the 
dark at 4°C, and the sa mples were then irrad iated for 10 min with 
a UV lamp. T he irrad iate<;l samples were pipetted into 20 p,1 of 
a stop so lu tion con taining 9% sod ium dodecy l sulfate (SOS), 15% 
glycerol, 3 mM EDT A, 30 mM Tris buffer, pH S, and heated at 
100°C for 20 s. Two microli ters of 2-merca ptoethanol anti 5 p,1 
of 0.1 % bromophenol blue in 50% glycerol were then added. 
T he sa mples were subj ected to 5-10% grad ient polyacry lamide 
slab gel electrophoresis in th e presence of SOS. T he gels were 
either dri ed and auto rad iography ca rri ed out at - SO°C using 
Cronex 4 Dupont de N emours medical x- ray fi lm or cut into 2-
mm slices and radioactivity determined. The autoradiographs were 
scanned with a microdensitometer. When ca re was taken not to 
saturate th e x-ray fi lm , th e peak heights of th e densito metri c scans 
were proportional in all in stances to the total rad ioactivity of the 
correspond ing peaks estimated by scintillation co unting as in Wa I-
ter et al [1 9]. T he values of R I and RII were calculated by inte-
g ratin g the areas under the curves obtained from the mi croden-
sitometric scans of the autoradiographs and subtracting the 
nonspecific labeling. In ex periments w here radioa cti vity in each 
band was quantitated, gels we re cut into 2-mm slices, and each 
slice was placed in a counting vial and dissolved by incubation 
w ith 0.2 m.l of Soluene 350 (Packard) at 37°C for 1 h. Five milli-
li ters of Instafluor (Packard) was th en added and radioactivity 
determ ined. 
Protein Kinase Assay Cycl ic AMP-depend ent protein kin ase 
activity was m easured as described by Roskoski [20], using kemp-
tide (a highl y specific substrate of cAMP-dependen t protein kin-
ases) as th e phos phate acceptor. Five microg rams' of cytosolic or 
membrane protein was used to ca ta lyze the transfer of 32p fro m 
ATP (5000 pmol, 5 X 105 cpm) to 4 p,g of kemptide, in the 
presence of 50 mM 3[N-Morpholino]propa ne sulfonic acid, pH 
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7.0, 250 p,g/ml bovine serum albumin , and 10 mM M gCI2 w ith 
or w ithout 1 p,M cAMP in a total vo lume of 50 p,1. The phos-
phory lation was allo wed to proceed at 30°C for 5 min and was 
terminated by spotting 25 p,1 of the reac tion mixture onto a PSI 
paper st rip w hi ch was dropped in ice-cold 5% phosphoric acid 
(10 ml/paper strip) . This was fo llowed by 3 more 5% phosphoric 
acid washes with swirling of the strips at 200 rpm for 2 min 
durin g each was h. After dryin g, the paper st rips were placed into 
scin till ation solvent and co unted. Background co unts determined 
in th e absence of enzyme were subtracted fro m all experimental 
va lues . Protein kinase acti vity is expressed as pmol of 32p trans-
fe rred to kemptide per min and per m g cytosoli c or membranes 
protein. T he level of cA MP-dependent protein kinase activity was 
ca lculated by sub tracting the am oun t of activity measured in the 
presence of 10 - (' M cA M P from the level of ac tivity m easured in 
the absence of cAMP. Protein concentrations were determined 
by fluorom etric assay using bovine serum albumin as th e standard 
[211- . 
RESULTS 
Effect of Retinoid Treatment of Normal and Psoriatic Fi-
broblasts on the Levels of RI and RII Regulatory Subunits 
To determine the effect of ex pos ure of normal an'd psoriatic hu-
man fibrob lasts to retino ic acid on the cA MP-dependent protein 
kinases, the levels of RI and RII , present in contro l and treated 
cells, were quantitated by photoaffi nity labeling w ith [S-azido-
32P]cAMP. The results presented in Figs 1 and 2 show 2 bands 
of specifi c IS-azido-32P]cAM P binding in the cytosol and plasma 
membrane fract ions prepared fro m normal human fibroblasts . 
T he m ajor band (Mr - 51,000) and the second band (Mr - 56,000) 
co rrespond to the RI and RII subunits, respectively. As previously 
shown [14], the levels of R I and RII are decreased in psoriatic 
fibroblasts esta blished from bo th involved and unin vo lved skin. 
Interestin gly, retinoic acid treatment of normal fibrob lasts does 
not change the levels of Rl and R H. H owever, w ith psoriatic 
fibrobl asts there is a clear in crease in both RI and RII with retinoic 
acid treatment. T he levels of R I and RII present in the cytosol 
and membrane fract ions prepared from fibroblasts es tabli shed 
from skin biopsies of 7 normal subj ects and 7 psoriatic subj ects 
are quantitated in Tables I and II. These results further substantia te 
that retinoic acid trea tment has no effect on the am ount of the 
RI and RII regulatory subunits fo un d in the subcellular fractions 
of normal fib roblasts. Similarly, w hen normal fibrobl as ts are treated 
for 4 days with. 13-cis-retinoic acid , arotino id , o r RO 101670, no 
changes in RI o I' R II levels are observed (data not shown). In 
pso riati c fibrob lasts the levels of RII are clearl y decreased, o r 
undetectab le relative to that of normal fib roblas ts, both in the 
cytosoli c and membrane fractions. The sa me deficiency in the 
type II regulatory subunit is observed in fibroblasts cultured fro m 
both in vo lved and unin volved skin obtained from the psoriatic 
subj ects. The amount of RI was norm al in the cytosolic fraction 
of fib roblasts of 5 out of 7 patients, and decreased in 2. Cytosols 
prepared from fibroblasts established from invo lved and unin-
vo lved skin of pso riatic subjects exhibit the sa me amount of the 
type I regu latory subuni t. M embrane-associated levels ofRI were 
fo und to be decreased relative to norm al in fibroblasts cultured 
from invo lved sk in of 5 psoriatic patients (B, C, 0, E , and F) 
and but were at norm al levels for 2 of the patients (A and G). 
Where determined (patients B, C, and 0), the levels ofRI at the 
membrane were si mil arl y modified in fibrobl asts cultured from 
both involved and uninvolved skin . 
Of particular interest is the find ing that retinoic acid treatment 
induces a clear increase in the amount of the Rl and RII regulatory 
subuni ts, w hen they are deficient, in the cytosolic and m embrane 
fract ions of psoriatic fib roblas ts. 
Effect of Retinoid Treatment of Normal and Psoriatic Fi-
broblasts on cAMP-Dependent· Protein Kinase Activity 
To further characterize the effect of retinoids on cAMP-dependent 
protein kinases, cAMP-dependent phosphotransferase activity was 
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Figure 1. Amoun t o f fS-azido-J2 PjcA MP specifica lly bound to the RI and RII regulato ry subunits of cAMP-dependent pro tein kinases present in the 
cytosolic fractions of no rm al and psoriati c fi bro blas ts (fro m involved and unin volved skin) treated o r untrea ted (control) fo r 3 days w ith 1 J.LM retino ic 
acid. Upper pal/el, Auto radiog raph showing the pho toactiva ted incorpo ratio n of jS-azido-J2 PjcA MP into cytosol cAMP binding proteins analyzed by 
SOS po lyacrylamide gel elec trophores is as described in Materials al/d Meth ods. T he subcellular frac tions were photoa ffi ni ty labeled w ith 1 J.LM [S-azido-
32PJcAMP in the presence and absence o f 10 J.LM cA MP as indica ted . O ne hundred micrograms o f cy tosolic pro tein was applied to each gel lane. Lower 
pa l/ el, Microdensitom etric scannings of these autoradiographs. T he va lues of RI and RII are shown by the area under the curves and by subtracting 
the nonspecific labe lin g (brokCII IiI/ e) no ted in the presence of unlabeled cA MP. Higher-molecular-weight pro teins are to the left fo r each densitom etri c 
scan . 
measured in the cytosolic and membrane fractions of fi broblas ts 
established fro m 4 no rm al subj ects and 4 psoriatic patients (Table 
III). Soluble cAMP-dependent protein kinase activity is not mod-
ified by retinoic acid treatment of norm al fib roblas ts. Particulate 
cAMP-dependent pro tein kinase acti vity in the same cells is either 
not modified or decreased (subj ects 2 and 8) by retinoic acid 
trea tment. However, retinoic acid treatment of fi broblas ts from 
uninvolved and in volved skin induced a clea r increase in cAMP-
PSORIATIC FIBROBLASTS 
dependent protein kinase activity in the cytosol o f 2 psoriati c 
patients (B and C) and in the membranes o f all 4 psoriatic subjects. 
D ISC U SSION 
Retinoid treatment of numerous cell systems has been shown to 
alter important biochemical and cellular properties. For exa mple, 
retinoids retard tumorigenesis in many experimental syste'ms 
(22,23], inhibit the growth of several cell types in cultu re, in-
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Figure 2. Am o unt o f[S-azido- 32PJcA MP specifica lly bound to the RI and Rll'regulato ry subuni ts of CAM P-dependen t pro tein kinases present in the 
membranes of no rmal and psoriatic fibro blas ts (fro m involved and uninvolved skin) t rea ted o r untrea ted (contro l) fo r 3 days w ith 1 J.LM retinoic acid. 
Legend sa m e as fo r Fig 1. 
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Table I. Regulatory Subunits of Cyelic AMP-D ependent Protein Kinases in the Cytosol of N or m al and Psoriatic Fibroblasts 
Psoriatic Fibroblasts N orm al Fibroblasts 
RI RII RI RII 
Subject Control +RA Control +RA Subject Control +RA Control + RA 
A 
Un in volved skin 1119 1078 413 406 
In vo lved skin 1090 1200 214 480 
B 
Uninvolved skin 706 1589 79 451 2 1395 1201 484 523 
Involved skin 822 1371 194 348 
C 
Uninvolved skin 752 1512 400 547 3 1000 1010 500 460 
In vo lved sk in 603 1681 398 609 
0 
Uninvolved skin 1290 1305 218 425 4 1340 1028 470 303 
Involved skin 1456 1495 229 413 
E 
Uninvolved skin 1072 1024 235 260 5 846 910 302 320 
Involved skin 909 840 91 197 
F 
Uninvolved ski n 6 1285 1300 372 392 
Inv" lved skin 1210 11 70 80 220 
G 
Uninvolved skiJl 7 1075 406 
Involved sk in 966 990 Undetectable 214 
Effect of retinoic acid (RA) treatment On the amount of I8-azido-"PlcAMP specifi call y bound to proteins present in the cytosolic fra ction of normal and psoriatic fibroblasts . 
Cytosolic frac tion was prepared from cultured fibrob lasts established from skin biopsies (from uni nvolved and involved skin in psoriatic patients) as indicated, either trea ted 
or untrea ted (control) fo r 3-4 days with 1 iJ.M RA. One hundred micrograms of protein was photoafftnity labeled with I iJ.M [8-azido-" l'jcAMP in the presence and absence 
of 10 iJ.M cAMP and then ana lyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The amount of " I' bound was quantitated by densitometric scanning of 
the auto radiograph of the gel. Nonspecific labeling (noted in the presence of added cA MP) was subtracted and levels of RI and RII were calcula ted based on the specific 
activity of [8-azido-" PlcA MP. Results arc the mean of dup licate determinations and expressed in femtomolcs bound per milligram of protein of the cell fraction. 
eluding fibrob lasts [24-26], and are requi red for normal epithelial 
ce ll d iffe rentiation [27]. Thus there is con siderable inte rest in elu-
cidating the m echanis m by which retinoic acid mediates cell g rowth 
and different iation. In this regard retinoic acid trea tment ofB16Fl 
murine melanoma cells [28] a nd F9 teratocarcinoma cells [18] h as 
been sh own to significantly increase cAMP-dependent protein 
kinase activity, suggesting that this effect o n protein kinase m ay 
be in volved in mediating some of the actions of retinoic acid . 
Epidermal hyperplasia associated with an inflamm atory process 
is the most p rominent indication of psoriasis lesion s. H owever, 
recent studies offer eviden ce that dermis h as a predominant role 
in the appearance of psori atic lesion s, w hi ch combines benign 
h yperpro liferation with abn ormal differentiation [29]. 
In this communicatio n we present additio n al evidence to sup-
port our initi al observation that there is a deficiency of cAMP-
d ep endent pro tein kinases in human psoriatic fibroblasts [14] . Of 
Table II. R egulatory Subuni ts of Cyclic AMP-Dependent Protein Kinases in the M embran es of N o rmal and Psoriatic Fibroblasts 
Psoriati c Fibroblas ts Normal Fibroblasts 
RI RII RI lUI 
Subject Control +RA Control +RA Subject Contro l +RA Control +RA 
A 
Uninvolved sk in 920 910 308 315 
Invo lved skin 980 1012 217 445 
B 
Uninvolved skin 518 832 132 343 2 882 922 376 442 
Invo lved skin 671 878 213 299 
C 
Unin volved skin 557 898 70 114 3 
Invo lved skin 516 595 98 120 
0 
Uninvolved sk in 983 1462 Undetectable 414 4 752 716 268 248 
Involved skin 550 802 107 362 
E 
Uninvolved skin 5 1049 393 
Involved skin 475 878 175 267 
F 
Uninvolved skin 6 1201 11 80 414 420 
Involved skin 610 915 Undetectable 418 
G 
Uninvolved skin 7 1010 412 
Involved skin 854 648 Undetectable 158 
Effect of retinoic acid (RA) treatment on the amount of 18-azido-J2PjcA MP specifically bound to proteins present in the membrane fraction of normal and psoriatic 
fibrob lasts. Membrane fractions we re prepared from cu ltured normal and psoriatic fibroblasts (from ininvolved and involved skin in psoriatic pa tients), either trea ted or 
untreated (control) for 3-4 days with 1 iJ.M RA. Legend same as for Table l. 
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Table III. Cyclic AMP-Dependent Protein Kinase Activity 
Cytosolic Membrane Associated 
Subjects Control +RA Control +RA 
Normal pmol J2p in corporated / min / mg protein pmol J2p inco rporatcd/ min / mg protein 
2 
4 9913 98 10 420 202 
5 11 200 9108 2064 1888 
8 8969 8342 1480 1556 
7957 7745 765 351 
Psoriatic 
B 
Unin volved skin 4974 7885 1606 1841 
In vol ved skin 7219 13420 1463 2431 
C 
Uninvolved skin 9183 12577 184 356 
Involved skin 4185 9481 1359 2076 
D 
Uninvolved skin 10587 101 30 1543 1847 
In volved skin 12699 15464 1976 3140 
H 
Unin volved skin 7251 7991 631 11 88 
In volved ski n 8850 9534 476 11 81 
Effect o f retinoi c acid (RA ) on cAMP-dependent protein kinase activity in normal and psoriatic fibroblasts (from invol ved and unin vo lv.ed ski n). Cells wcre either treated 
or untreated (control) for 3-4 days with RA prior to the preparation of cy tosolic and membrane fractions. Phosphotransfcrase acti vity was measured 111 the presence and 
absence of I f.LM cAMP, and the level of cAMP-dependent activity was calculated by subtraction of cAMP-independ ent activity as described in Marerials alld Merhods. 
Kemptide phosphorylation is expressed as picomol o f J2p, transferred per min per mg o f pro tein of the cell fract ion. Results arc the mean of 2 expenments. 
interest is the fact that fibroblasts cultured from both uninvolved 
and involved skin show the same deficiency in the cAMP-de-
pendent protein kinases. This findin g further supports the sug-
gestion that psoriatic fibrob lasts from lesional and nonlesional 
tissue have the same characteristics [30]. Retinoid treatment of 
fibroblasts which exhibit a deficiency [14] in cAMP-dependent 
protein kinases induces a significant increase of these enzymes to 
the norma l level. At the concentration tes ted (1 J.LM) retinoic acid, 
13-cis- retinoic acid, and arotinoid all promoted the same effect 
with psoriatic fibroblasts . This similar in vitro efficiency of these 
retinoids is in contrast w ith their therapeutic effects which have 
been shown to be markedly different in psoriasis [31]. 
Protein kinases are the intracellular mediators of cA M Paction 
[5] . A deficiency of these enzymes would result in low, and may 
be responsible for abnormal cAMP-mediated phosphorylations 
of specific endogenous proteins. The restoration of these enzymes 
to normal levels would allow normal cAMP-dependent phos-
phorylations of endogenous substrates which may play a critical 
role in mediating cell growth and differentiation. This in vitro 
effect of retinoids on psoriatic fibroblasts may help to explain 
some of the in vivo therapeutic effects of retinoids. The retinoid-
induced increase in cAMP-dependent protein kinase activity in 
psoriatic fibroblasts conceivably acts to sens iti ze the treated cells 
to elevations in cAMP levels to respond to the cyclic nucleotide 
with changes toward normal in growth rate and other biologic 
properties. This suggests that a combination of retinoids and 
cAMP analogs or agents which elevate intracellular cAMP may 
be an advisable approach in the therapeutic treatment of certain 
types of psoriasis. 
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